涉及重复药物治疗的化疗药物测试分析。 - Suppr | 超能文献

Analysis of tests of chemotherapeutic agents involving repeated drug treatment.

作者信息

Ullman N S, Jacquez J A

出版信息

Biometrics. 1973 Dec;29(4):677-93.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Analysis of tests of chemotherapeutic agents involving repeated drug treatment.涉及重复药物治疗的化疗药物测试分析。

Biometrics. 1973 Dec;29(4):677-93.

2

Electronic volume analysis of L1210 chemotherapy.L1210化疗的电子体积分析

Cancer Res. 1976 Dec;36(12):4434-8.

3

Rationale of chemotherapeutic adjuvant treatment.化疗辅助治疗的基本原理。

Arch Geschwulstforsch. 1978;48(7):627-35.

4

Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.小鼠L1210白血病观察到的耐药性基础：以不同组合给予甲氨蝶呤、6-硫鸟嘌呤、6-甲基巯基嘌呤核苷、6-巯基嘌呤、5-氟尿嘧啶和1-β-D-阿拉伯呋喃糖基胞嘧啶。

Cancer Res. 1981 Nov;41(11 Pt 1):4529-34.

5

Antigenicity of L1210 leukemic sublines induced by drugs.药物诱导的L1210白血病亚系的抗原性

Cancer Res. 1972 Apr;32(4):653-7.

6

Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.两种抗癌药物的序贯给药：药效学增强模式的研究

Biomedicine. 1974 Dec 10;21(12):471-9.

7

[L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].[L1210白血病，一种用于增强急性白血病用药疗效的实验模型]

Bull Cancer. 1974 Oct-Dec;61(4):509-26.

8

High molecular weight derivatives of methotrexate as chemotherapeutic agents.甲氨蝶呤的高分子量衍生物作为化疗药物。

Mol Pharmacol. 1977 Jan;13(1):80-8.

9

[Transplantability, development and methotrexate sensitivity of mouse leukemia L1210 resistant to olivomycin].[对橄榄霉素耐药的小鼠白血病L1210的移植性、发育及甲氨蝶呤敏感性]

Antibiotiki. 1978 Jun;23(6):553-7.

10

Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.小鼠晚期白血病L1210中抗白血病药物的评价。X。

Cancer Chemother Rep 2. 1972 Nov;3(1):1-69.